Article Details

Pfizer strengthens AI drug discovery collaboration with equity investment

Retrieved on: 2022-09-26 19:28:59

Tags for this article:

Click the tags to see associated articles and topics

Pfizer strengthens AI drug discovery collaboration with equity investment. View article details on hiswai:

Excerpt

Pfizer and CytoReason have been partnered on artificial intelligence and machine learning technologies for drug discovery and development since ...

Article found on: www.outsourcing-pharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up